Featured Stories
U.S. Strategic Command Hosts Component Commanders Conference
OFFUTT AIR FORCE BASE, Nebraska, Sept. 22 -- The U.S. Strategic Command issued the following news:
* * *
Sept. 21, 2026
U.S. Strategic Command hosts Component Commanders Conference
OFFUTT AIR FORCE BASE, Neb. - U.S. Navy Adm. Rich Correll, commander of U.S. Strategic Command, hosted a Component Commanders Conference with key leaders from the USSTRATCOM Joint Force air and maritime components, 16th Air Force (Air Forces Cyber), and U.S. Army Space and Missile Defense Command, Sept. 10 at USSTRATCOM headquarters.
The conference brought together senior leaders from across the strategic enterprise
... Show Full Article
OFFUTT AIR FORCE BASE, Nebraska, Sept. 22 -- The U.S. Strategic Command issued the following news:
* * *
Sept. 21, 2026
U.S. Strategic Command hosts Component Commanders Conference
OFFUTT AIR FORCE BASE, Neb. - U.S. Navy Adm. Rich Correll, commander of U.S. Strategic Command, hosted a Component Commanders Conference with key leaders from the USSTRATCOM Joint Force air and maritime components, 16th Air Force (Air Forces Cyber), and U.S. Army Space and Missile Defense Command, Sept. 10 at USSTRATCOM headquarters.
The conference brought together senior leaders from across the strategic enterpriseto align priorities, discuss the operating environment and strengthen coordination among the air, maritime, cyber, space and missile defense capabilities supporting USSTRATCOM missions.
"Strategic deterrence depends on credible, integrated forces and the leaders who synchronize them every day," Correll said. "This conference reinforces our shared commitment to readiness, agility and the ability to respond across all domains."
Leaders emphasized that closer integration across the force maximizes flexibility and effectiveness by improving the command's ability to respond quickly, synchronize capabilities and provide credible options to national leadership.
U.S. Air Force Gen. S.L. Davis, commander of Air Force Global Strike Command and Air Forces Strategic-Air, emphasized the importance of integrating the Air Force's nuclear and conventional long-range strike capabilities with those of other USSTRATCOM components.
"America's Airmen are highly trained and poised to employ nuclear and conventional long-range strike capabilities at a moment's notice," Davis said. "They've proven time and time again, whether you need bombers in the skies or ICBM teams in the missile field, that the U.S. Air Force -- operating two-thirds of the nuclear triad -- is part of an integrated Joint Force team. Planning together is how we ensure USSTRATCOM maintains combat capability today and remains ready for tomorrow."
U.S. Navy Adm. Karl Thomas, commander, Joint Force Maritime Component Command, said the conference underscored the importance of unified planning and execution.
"Our maritime forces provide persistent, flexible and survivable capabilities that are essential to deterrence," Thomas said. "Working closely with our joint partners ensures we remain ready to deliver those capabilities whenever called upon."
U.S. Air Force Lt. Gen. Thomas Hensley, commander, 16th Air Force (Air Forces Cyber), highlighted the role of cyber and information capabilities in enabling the Joint Force.
"16th Air Force brings cyber and information capabilities that help ensure the Joint Force can operate, communicate and make decisions in contested environments," Hensley said. "Close coordination with our USSTRATCOM partners strengthens our collective readiness and provides national leaders resilient, integrated options across the competition continuum."
U.S. Army Lt. Gen. John Rafferty, commander, U.S. Army Space and Missile Defense Command, emphasized the value of integrating space and missile defense capabilities across the strategic enterprise.
"U.S. Army Space and Missile Defense Command provides critical space and high altitude, missile defense, and technical capabilities to USSTRATCOM that strengthens the nation's ability to deter and respond to strategic challenges," Rafferty said. "This conference brought together commanders from across the Joint Force in support of USSTRATCOM."
The commanders also discussed ongoing efforts to maintain strategic readiness, improve joint integration and ensure forces remain prepared to meet evolving mission requirements.
The component commanders returned to their commands with a renewed vision of USSTRATCOM's path forward and will meet periodically to develop and share novel solutions to emerging challenges across the strategic enterprise.
* * *
Original text here: https://www.stratcom.mil/Media/News/News-Article-View/Article/4607054/us-strategic-command-hosts-component-commanders-conference/
SEC Charges Brother of Former PetIQ Executive With Insider Trading
WASHINGTON, Sept. 22 -- The Securities and Exchange Commission issued the following litigation release:
* * *
Securities and Exchange Commission v. Michael T. Christensen, No. 26-cv-00618 (D. Idaho filed Sept. 21, 2026)
On September 21, 2026, the Securities and Exchange Commission filed insider trading charges against Michael T. Christensen of Boise, Idaho alleging that he unlawfully traded in the securities of PetIQ, Inc. ahead of the August 7, 2024 announcement that private equity firm Bansk Group LP would acquire PetIQ.
According to the SEC's complaint, Christensen purchased PetIQ stock
... Show Full Article
WASHINGTON, Sept. 22 -- The Securities and Exchange Commission issued the following litigation release:
* * *
Securities and Exchange Commission v. Michael T. Christensen, No. 26-cv-00618 (D. Idaho filed Sept. 21, 2026)
On September 21, 2026, the Securities and Exchange Commission filed insider trading charges against Michael T. Christensen of Boise, Idaho alleging that he unlawfully traded in the securities of PetIQ, Inc. ahead of the August 7, 2024 announcement that private equity firm Bansk Group LP would acquire PetIQ.
According to the SEC's complaint, Christensen purchased PetIQ stockand options on the basis of material nonpublic information that he learned from his brother, a former PetIQ senior executive who was then an integral part of the deal discussions. As alleged, Christensen and his brother vacationed together late-June through early-July 2024, during a time when Christensen's brother was actively engaged in PetIQ's negotiations with Bansk. According to the complaint, Christensen's brother disclosed material, nonpublic information about the potential acquisition to Christensen, who then traded on that information by purchasing shares of PetIQ stock and options in July and August 2024 and continued to do so until the day before the public announcement. The complaint further alleges that the day the acquisition was announced, the price of PetIQ's stock rose 48%, and Christensen made approximately $299,000 in illicit profits.
The SEC's complaint, filed in federal court in the District of Idaho, charges Christensen with violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder and seeks a permanent injunction, disgorgement with prejudgment interest, and a civil penalty.
Christensen previously pleaded guilty to securities fraud in a parallel criminal action brought by the U.S. Department of Justice.
The SEC's investigation, which is continuing, was conducted by Andrew Palid, David Scheffler, John Rymas, and Michele T. Perillo of the Division of Enforcement's Market Abuse Unit, under the supervision of Joseph G. Sansone. Kathleen Shields of the SEC's Boston Regional Office will lead the litigation. The SEC appreciates the assistance of the U.S. Department of Justice Criminal Division's Fraud Section, the U.S. Postal Inspection Service, and the Financial Industry Regulatory Authority.
* * *
Resources
* SEC Complaint (https://www.sec.gov/files/litigation/complaints/2026/comp26644.pdf)
* * *
Original text here: https://www.sec.gov/enforcement-litigation/litigation-releases/lr-26644
President Trump Issues Statement on Yom Kippur
WASHINGTON, Sept. 22 -- President Trump issued the following statement on Sept. 20, 2026, on Yom Kippur:
* * *
On the holiest day of the Jewish calendar, I send my best wishes to the entire Jewish community for a blessed Yom Kippur.
As it is referred to in the Torah as the "Sabbath of Sabbaths," Yom Kippur empowers those of the Jewish faith to renew their unwavering relationship with the Creator through fasting, prayer, and charity. As the High Holy Days come to a close, and the fate of the year ahead is inscribed and sealed, my Administration is resolved to defend every American's sacred right
... Show Full Article
WASHINGTON, Sept. 22 -- President Trump issued the following statement on Sept. 20, 2026, on Yom Kippur:
* * *
On the holiest day of the Jewish calendar, I send my best wishes to the entire Jewish community for a blessed Yom Kippur.
As it is referred to in the Torah as the "Sabbath of Sabbaths," Yom Kippur empowers those of the Jewish faith to renew their unwavering relationship with the Creator through fasting, prayer, and charity. As the High Holy Days come to a close, and the fate of the year ahead is inscribed and sealed, my Administration is resolved to defend every American's sacred rightto freedom of religion.
May the Almighty bless you all with renewed strength and abundant faith on this holy day, and may He continue to bless the United States of America.
* * *
Original text here: https://www.whitehouse.gov/briefings-statements/2026/09/presidential-message-on-yom-kippur-a68b/
NIH Makes Major Investments to Advance Human-based Research Infrastructure and Technologies
WASHINGTON, Sept. 22 -- The U.S. Department of Health and Human Services National Institutes of Health issued the following news release:
* * *
September 21, 2026
NIH makes major investments to advance human-based research infrastructure and technologies
Projects spanning the nation will accelerate scientific discovery, reduce reliance on animals.
-
The National Institutes of Health (NIH) is making its biggest push yet to move biomedical research beyond animal model use, unveiling five major initiatives that could reshape how new drugs and treatments are developed and evaluated. Together,
... Show Full Article
WASHINGTON, Sept. 22 -- The U.S. Department of Health and Human Services National Institutes of Health issued the following news release:
* * *
September 21, 2026
NIH makes major investments to advance human-based research infrastructure and technologies
Projects spanning the nation will accelerate scientific discovery, reduce reliance on animals.
-
The National Institutes of Health (NIH) is making its biggest push yet to move biomedical research beyond animal model use, unveiling five major initiatives that could reshape how new drugs and treatments are developed and evaluated. Together,the efforts signal a significant investment into human-based technologies as the future of preclinical science, aiming to make research faster, more predictive, and more directly relevant to human health.
Efforts include more than $88 million in funding for biomedical infrastructure projects nationwide; a new challenge offering over $7 million in awards to demonstrate how quantum-enabled approaches can improve detection and measurement in lab-based New Approach Methodologies (NAMs); a state-of-the-art laboratory at the NIH Clinical Center that will integrate standardized human organoid models, robotics, AI, and advanced data capabilities to enable experiments on reproducible human biological systems; an initiative to recruit grant reviewers who are experts in human-based science; and a new request for information from the scientific community to assess the feasibility of an annual public report tracking the number of vertebrate animals used in NIH-funded research.
"NIH is building the scientific infrastructure needed to develop, validate, and scale technologies that better reflect human biology," said NIH Director Jay Bhattacharya, M.D., Ph.D. "Our goal is to give researchers better tools to understand human disease and translate discoveries into treatments that improve patients' lives."
Part of NIH's Biomedical Research Facilities Program, 10 construction projects totaling $88 million, located across the nation, will spur the advancement of NAMs and enable investigation into a host of major health issues facing Americans, including chronic disease, environmental health, rare childhood diseases, cancer research, obesity and metabolic dysfunctions. Traditionally, many awards in this program have supported the construction and renovation of research infrastructure focused on further development of animal models for research. While animal models are still an important tool for human biomedical discovery, NIH's goal is to reduce the use of animals whenever feasible.
These new awards also reflect NIH's commitment to a broad geographical distribution of taxpayer funds, with awardees representing nine states from coast to coast. Several of the grants are to institutions in NIH Institutional Development Award (IDeA) States, with a focus on building research capacity in areas that traditionally lag peer states in health care technology, services, or research resources and where these lags may adversely affect the health status of the local population in the future.
"We are at a unique moment in biomedical research, with new tools and technologies giving us an unprecedented opportunity to advance research methodologies that more closely reflect human biology," said Nicole Kleinstreuer, Ph.D., NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives. "But realizing that opportunity requires a strong foundation and a research enterprise with the capacity to innovate across the country. These new awards will help build that foundation by expanding access to resources, expertise and infrastructure, ensuring that scientists with transformative ideas will advance the next generation of biomedical research."
The Quantum-Enabled Approaches for Predictive Preclinical NAMs for Toxicity and Safety (Qu-SAFE) Challenge seeks proof-of-concept and prototype sensing systems that use quantum technology, either alone or combined with classical methods, to improve how researchers detect and measure biological signals in lab-based NAMs systems used for drug safety and toxicity evaluation. This includes tools such as organ-on-a-chip devices that generate human-relevant data without relying on animal models. The challenge's goal is to unlock new kinds of biological data and signals that can't currently be measured, making these preclinical models better at predicting real-world drug safety and effectiveness. Top submissions will earn portions of prizes totaling over $7 million.
NIH will also establish a Bio Genesis Autonomous Human Biology Laboratory within the NIH Clinical Center, aligned with the NIH Standardized Organoid Modeling (SOM) Center, to integrate standardized human organoid models, robotics, AI, and advanced data capabilities into a closed-loop experimental platform to enable clinically driven questions to be tested in reproducible human biological systems. These new lab systems will generate data that continuously informs the next experiment and accelerates translation while reducing reliance on animal models.
Two final efforts include a newly issued request for information (RFI) to seek input from domestic and foreign NIH-funded institutions on the reporting of laboratory animal numbers, and a push to recruit reviewers with expertise in human-based science. For the first, NIH's Office of Laboratory Animal Welfare (OLAW) is gathering input on feasibility, current capabilities, expected benefits, and expected burdens associated with yearly reporting of the number of live, vertebrate animals in NIH-funded labs. This effort would increase transparency regarding animal use and would assist the agency in measuring the progress of its work to reduce the use of animals in NIH-supported research. For the second, NIH recognizes that the agency needs robust expertise to help review the many new facets of science presented by human-based approaches. Building up this expertise in the peer review process will help ensure relevant experts are included in the evaluation of these new technologies and projects and help facilitate the shift of research from animal-based methods to human-based science. Experts in human-based science are encouraged to express their interest here.
* * *
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH...Turning Discovery Into Health(R)
* * *
Original text here: https://www.nih.gov/news-events/news-releases/nih-makes-major-investments-advance-human-based-research-infrastructure-technologies
FDA Recall Notice: Par Health Recalls Two Lots of Dexmedetomidine Injection Over Particulates
WASHINGTON, Sept. 22 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following recall notice:
* * *
Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter
Summary
Company Announcement Date: September 18, 2026
FDA Publish Date: September 21, 2026
Product Type: Drugs
Reason for Announcement: Presence of particulate matter identified as cellulose or stopper material
Company Name: Par Health
Brand Name: Par Pharmaceutical
Product Description: Dexmedetomidine
... Show Full Article
WASHINGTON, Sept. 22 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following recall notice:
* * *
Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter
Summary
Company Announcement Date: September 18, 2026
FDA Publish Date: September 21, 2026
Product Type: Drugs
Reason for Announcement: Presence of particulate matter identified as cellulose or stopper material
Company Name: Par Health
Brand Name: Par Pharmaceutical
Product Description: DexmedetomidineHCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) for Intravenous Infusion
Company Announcement
ROCHESTER, MI- September 18, 2026 -Par Health is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose or stopper material.
Administration of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL, found to contain particulate matter, has a reasonable probability of causing life-threatening adverse health consequences including pulmonary emboli (blockage in pulmonary blood vessels), occlusions of other blood vessels (which can lead to tissue death and possible organ damage), and/or inflammation of the walls of veins, which may lead to clotting. To date, Par Health has not received any reports of adverse events related to this recall.
Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) is formulated for intravenous infusion. The product is indicated for sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting and for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.
* * *
TABLE: Recalled product can be identified as follows and by labels at bottom of this document
* * *
These lots were distributed nationwide to wholesalers between May 13, 2025 and June 29, 2025.
Par Health is providing written notification to wholesale accounts that have received the affected lots and are arranging for return of all existing inventory of Lots 87558 and 88802 through Inmar, Inc. Wholesale distributors and hospital pharmacies that have the product being recalled should immediately discontinue use and stop distribution. If you have further distributed the recalled product, please notify your accounts or any additional locations which may have received the recalled product.
Questions regarding this recall can be directed to Inmar, Inc. at 1-833-599-3197 Monday through Friday between the hours of 9 a.m. and 5 p.m. ET or by email at rxrecalls@inmar.com.
For medical or technical product information or to report a product complaint or adverse event please call 1-800-828-9393 Monday through Thursday between the hours of 9 a.m. and 8 p.m. ET or Friday between 9 a.m. and 6 p.m. ET.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
* Complete and submit the report Online: www.fda.gov/medwatch/report.htm
* Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
* * *
Original text here: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/par-health-issues-voluntary-nationwide-recall-two-lots-dexmedetomidine-hcl-09-sodium-chloride
FCC Wireline Competition Bureau Issues Public Notice: Comments Invited on CenturyLink's Section 214 Application to Discontinue Domestic Legacy Voice Service as Part of Technology Transition
WASHINGTON, Sept. 22 -- The Federal Communications Commission's Wireline Competition Bureau issued the following public notice (WC Docket No. 26-247):
* * *
Unless otherwise specified, the following procedures and dates apply to the application(s) (the Section 214 Discontinuance Application(s)) listed in the Appendix.
The Wireline Competition Bureau (Bureau), upon initial review, has found the Section 214 Discontinuance Application(s) listed herein to be acceptable for filing and subject to the procedures set forth in Section 63.71 of the Commission's rules./1 The application(s) request authority,
... Show Full Article
WASHINGTON, Sept. 22 -- The Federal Communications Commission's Wireline Competition Bureau issued the following public notice (WC Docket No. 26-247):
* * *
Unless otherwise specified, the following procedures and dates apply to the application(s) (the Section 214 Discontinuance Application(s)) listed in the Appendix.
The Wireline Competition Bureau (Bureau), upon initial review, has found the Section 214 Discontinuance Application(s) listed herein to be acceptable for filing and subject to the procedures set forth in Section 63.71 of the Commission's rules./1 The application(s) request authority,under section 214 of the Communications Act of 1934, as amended,/2 and section 63.71 of the Commission's rules,/3 to discontinue, reduce, or impair certain domestic telecommunications service(s) (Affected Service(s)) in specified geographic areas (Service Area(s)) as applicable and as fully described in each application.
In accordance with section 63.71(f) of the Commission's rules, the Section 214 Discontinuance Application(s) listed in the Appendix will be deemed granted automatically on October 22, 2026, the 31st day after the release date of this public notice, unless the Commission notifies any applicant(s) that their grant will not be automatically effective./4 We note that the date on which an application for Commission authorization is deemed granted may be different from the date on which applicants are authorized to discontinue service ("Authorized Date"). Any applicant whose application has been deemed granted may discontinue their Affected Service(s) in their Service Area(s) on or after the authorized discontinuance date(s) specified in the Appendix, in accordance with their filed representations. Accordingly, pursuant to section 63.71(f), and the terms outlined in each application, absent further Commission action, each applicant may discontinue the Affected Service(s) in the Service Area(s) described in their application on or after the authorized discontinuance date(s) listed in the Appendix for that application. For purposes of computation of time when filing a petition for reconsideration, application for review, or petition for judicial review of the Commission's decision(s), the date of "public notice" shall be the later of the auto grant date stated above in this Public Notice, or the release date(s) of any further public notice(s) or order(s) announcing final Commission action, as applicable. Should no petitions for reconsideration, applications for review, or petitions for judicial review be timely filed, the proceeding(s) listed in this Public Notice shall be terminated, and the docket(s) will be closed.
Comments objecting to the application listed in the Appendix must be filed with the Commission on or before October 6, 2026. Comments should refer to the specific WC Docket No. and Comp. Pol. File No. listed in the Appendix for the Section 214 Discontinuance Application. Comments should include specific information about the impact of the proposed discontinuance on the commenter, including any inability to acquire reasonable substitute service. Comments may be filed using the Commission's Electronic Comment Filing System (ECFS). Electronic Filers: Comments may be filed electronically using the Internet by accessing the ECFS: https://www.fcc.gov/ecfs. Filers should follow the instructions provided on the Web site for submitting comments. Generally, only one copy of an electronic submission must be filed. In completing the transmittal screen, filers should include their full name, U.S. Postal Service mailing address, and the applicable docket number./5
Paper Filers: Parties who choose to file by paper must file an original and one copy of each filing. Filings can be sent by hand or messenger delivery, by commercial courier, or by the U.S. Postal Service. All filings must be addressed to the Secretary, Federal Communications Commission. Hand-delivered or messenger-delivered paper filings for the Commission's Secretary are accepted between 8:00 a.m. and 4:00 p.m. by the FCC's mailing contractor at 9050 Junction Drive, Annapolis Junction, MD 20701. All hand deliveries must be held together with rubber bands or fasteners. Any envelopes and boxes must be disposed of before entering the building. Commercial courier deliveries (any deliveries not by the U.S. Postal Service) must be sent to 9050 Junction Drive, Annapolis Junction, MD 20701. Filings sent by U.S. Postal Service First-Class Mail, Priority Mail, and Priority Mail Express must be sent to 45 L Street NE, Washington, DC 20554.
This proceeding shall be treated as a "permit-but-disclose" proceeding in accordance with the Commission's ex parte rules./6 Persons making ex parte presentations must file a copy of any written presentation or a memorandum summarizing any oral presentation within two business days after the presentation (unless a different deadline applicable to the Sunshine period applies). Persons making oral ex parte presentations are reminded that memoranda summarizing the presentation must (1) list all persons attending or otherwise participating in the meeting at which the ex parte presentation was made, and (2) summarize all data presented and arguments made during the presentation. If the presentation consisted in whole or in part of the presentation of data or arguments already reflected in the presenter's written comments, memoranda or other filings in the proceeding, the presenter may provide citations to such data or arguments in his or her prior comments, memoranda, or other filings (specifying the relevant page and/or paragraph numbers where such data or arguments can be found) in lieu of summarizing them in the memorandum. Documents shown or given to Commission staff during ex parte meetings are deemed to be written ex parte presentations and must be filed consistent with rule 1.1206(b). In proceedings governed by rule 1.49(f) or for which the Commission has made available a method of electronic filing, written ex parte presentations and memoranda summarizing oral ex parte presentations, and all attachments thereto, must be filed through the electronic comment filing system available for that proceeding, and must be filed in their native format (e.g., .doc, .xml, .ppt, searchable .pdf). Participants in this proceeding should familiarize themselves with the Commission's ex parte rules.
People with Disabilities: To request materials in accessible formats for people with disabilities (braille, large print, electronic files, audio format), send an e-mail to fcc504@fcc.gov or call the Consumer & Governmental Affairs Bureau at 202-418-0530.
For further information, please see the contact(s) for the specific discontinuance proceeding you are interested in as listed in the Appendix. For further information on procedures regarding section 214 please visit https://www.fcc.gov/general/domestic-section-214-discontinuance-service.
* * *
Appendix
1) Applicant(s): Qwest Corporation d/b/a CenturyLink QC
WC Docket No. 26-247, Comp. Pol. File No. 2202
Link - https://www.fcc.gov/ecfs/search/search-filings/results?q=(proceedings.name:(%2226247%22))
Affected Service(s) - legacy voice service
Service Area(s) - a portion of the Fort Wingate, New Mexico wire center, as specified in the application
Authorized Date(s) - on or after December 7, 2026
* * *
Footnotes:
1/ 47 CFR Sec. 63.71.
2/ 47 U.S.C. Sec. 214.
3/ 47 CFR Sec. 63.71.
4/ See 47 CFR Sec. 63.71(f)(1) (stating, in relevant part, that an application filed by a non-dominant carrier "shall be automatically granted on the 31st day... unless the Commission has notified the applicant that the grant will not be automatically effective"); see also 47 CFR Sec. 63.71(f)(2)(i) (stating that "[a]n application to discontinue, reduce, or impair an existing retail service as part of a technology transition, as defined in Sec. 63.60(i), may be automatically granted... if: The applicant provides affected customers with the notice required under paragraph (a)(6) of this section, and the application contains the showing or certification described in Sec. 63.602(b)"); Accelerating Wireline Broadband Deployment by Removing Barriers to Infrastructure Investment, WC Docket No. 17-84, Order, DA 25248, para. 6 (WCB Mar. 20, 2025) (waiving the Adequate Replacement Test's "single replacement service" requirement for a period of two years when a carrier seeks to discontinue a legacy voice service pursuant to section 214(a), thereby allowing carriers to satisfy all three prongs of the Adequate Replacement Test with a bundled service); Technology Transitions, GN Docket No. 13-5, Order on Clarification, DA 25-250, para. 6 (WCB Mar. 20, 2025) (clarifying the applicability of the testing methodology and parameters required for meeting the streamlining criteria when a carrier submits a technology transition discontinuance application relying on the "totality of the circumstances" under the Adequate Replacement Test)).
5/ Please note that Commission staff may share filed comments with the applicant(s), along with the commenter's contact information, in order to allow applicant(s) to identify affected customers in the proposed discontinuance area and fully respond.
6/ 47 CFR Sec. 1.1200 et seq.
* * *
Original text here: https://docs.fcc.gov/public/attachments/DA-26-1013A1.pdf
Economics Daily: Total Employment Projected to Grow 3.5 Percent Between 2025 and 2035
WASHINGTON, Sept. 22 -- The U.S. Department of Labor Bureau of Labor Statistics issued the following document from Economics Daily:
* * *
Total employment projected to grow 3.5 percent between 2025 and 2035
September 21, 2026
Employment is projected to grow 3.5 percent between 2025 and 2035. The two major occupational groups projected to grow the fastest are healthcare support (+13.3 percent) and healthcare practitioners and technical (+8.0 percent). These two healthcare groups combined are expected to account for almost one-third of all new jobs created through 2035.
Life, physical, and social
... Show Full Article
WASHINGTON, Sept. 22 -- The U.S. Department of Labor Bureau of Labor Statistics issued the following document from Economics Daily:
* * *
Total employment projected to grow 3.5 percent between 2025 and 2035
September 21, 2026
Employment is projected to grow 3.5 percent between 2025 and 2035. The two major occupational groups projected to grow the fastest are healthcare support (+13.3 percent) and healthcare practitioners and technical (+8.0 percent). These two healthcare groups combined are expected to account for almost one-third of all new jobs created through 2035.
Life, physical, and socialscience occupations are projected to experience the third-fastest job growth of any major occupational group (+7.5 percent). The growing demand for scientific research and development in a wide range of fields, most notably in biotechnology, manufacturing, and artificial intelligence (AI), is the main factor expected to drive strong employment demand in this group.
The major occupational groups with the next fastest projected employment growth are community and social service occupations (+7.4 percent) and computer and mathematical occupations (+7.3 percent). Fast job growth in computer and mathematical occupations is expected to largely stem from the continued proliferation of digital tools and AI solutions across the economy.
Although the growing adoption of AI is expected to support demand for some occupations, associated productivity gains may dampen employment demand for others. The continued integration of automation tools, including those powered by AI, into workflows is likely to reduce demand for several office and administrative support occupations. Employment in this group is projected to decline at the fastest pace (-4.0 percent) of any major occupational group and to shed the most jobs (-752,100).
Other occupational groups in which employment is projected to decline over the 2025-35 decade are farming, fishing, and forestry (-1.5 percent); sales and related (-1.4 percent); and production (-0.4 percent).
These data are from the Employment Projections program. For more information, see "Employment Projections -- 2025-2035". Also see the Occupational Outlook Handbook which includes information on about 600 detailed occupations in over 300 occupational profiles, covering about 4 out of 5 jobs in the economy. Each occupational profile features the 2025-35 projections, along with assessments of the job outlook, work activities, wages, education and training requirements, and more.
SUGGESTED CITATION
Bureau of Labor Statistics, U.S. Department of Labor, The Economics Daily, Total employment projected to grow 3.5 percent between 2025 and 2035 at https://www.bls.gov/opub/ted/2026/total-employment-projected-to-grow-3-5-percent-between-2025-and-2035.htm (visited September 22, 2026).
* * *
View original text plus charts and tables here: https://www.bls.gov/opub/ted/2026/total-employment-projected-to-grow-3-5-percent-between-2025-and-2035.htm
